Determination of PF-04928473 in human plasma using liquid chromatography with tandem mass spectrometry
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-11-15
著者
-
VENITZ Jurgen
Department of Pharmaceutical Sciences, Virginia Commonwealth University
-
Figg William
Clinical Pharmacology Program Center For Cancer Research National Cancer Institute
-
Gardner Erin
Clinical Pharmacology Program Saic-frederick Inc.
-
Gardner Erin
Clinical Pharmacology Program Saic-frederick Inc. Nci-frederick
-
JAIN Lokesh
Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute
-
GIACCONE Giuseppe
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute
-
HOUK Brett
Department of Clinical Pharmacology, Pfizer, Inc., 10578 Science Center Drive
-
Jain Lokesh
Clinical Pharmacology Program Center For Cancer Research National Cancer Institute
-
Giaccone Giuseppe
Medical Oncology Branch Center For Cancer Research National Cancer Institute
-
Houk Brett
Department Of Clinical Pharmacology Pfizer Inc. 10578 Science Center Drive
-
Venitz Jurgen
Department Of Pharmaceutics School Of Pharmacy Virginia Commonwealth University
関連論文
- Determination of MS-275, a novel histone deacetylase inhibitor, in human plasma by liquid chromatography-electrospray mass spectrometry
- Quantitative determination of perifosine, a novel alkylphosphocholine anticancer agent, in human plasma by reversed-phase liquid chromatography-electrospray mass spectrometry
- Determination of the heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin in plasma by liquid chromatography-electrospray mass spectrometry
- Determination of CC-5013, an analogue of thalidomide, in human plasma by liquid chromatography-mass spectrometry
- Determination of the cyclic depsipeptide FK228, a histone deacetylase inhibitor, by liquid chromatography-mass spectrometry
- Determination of midazolam in human plasma by liquid chromatography with mass-spectrometric detection
- Determination of the antiangiogenesis agent 2-methoxyestradiol in human plasma by liquid chromatography with ultraviolet detection
- Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment
- Determination of 17-dimethylaminoethylamino-17-demethoxygeldanamycin in human plasma by liquid chromatography with mass-spectrometric detection
- Determination of PF-04928473 in human plasma using liquid chromatography with tandem mass spectrometry
- Determination of a benzamide histone deacetylase inhibitor, MS-275, in human plasma by liquid chromatography with mass-spectrometric detection
- Determination of the cyclic depsipeptide FK228 in human and mouse plasma by liquid chromatography with mass-spectrometric detection